These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2576110)

  • 1. Fructose-added glycerol (Glyceol) for therapy of elevated intracranial pressure: analysis of the side effects of long-term administration in a multi-institutional trial.
    Tsubokawa T; Katayama Y; Ishii S
    Neurol Res; 1989 Dec; 11(4):249-52. PubMed ID: 2576110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of long-term administration of Glyceol].
    Ishikawa M; Handa H; Handa J; Hirakawa K; Nakamura T; Fukuma S; Hakusui S; Taketomo S; Odawara K; Nisimura T
    Nihon Geka Hokan; 1986 Jul; 55(4):585-96. PubMed ID: 3827488
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperlactatemia caused by intra-venous administration of glycerol: A case study.
    Katayama S; Nunomiya S; Wada M; Misawa K; Tanaka S; Koyama K; Koinuma T
    Indian J Crit Care Med; 2012 Oct; 16(4):241-4. PubMed ID: 23559739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glycerol for the treatment of traumatic intracranial hypertension.
    Wald SL; McLaurin RL
    J Neurosurg; 1982 Mar; 56(3):323-31. PubMed ID: 7057229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of increased intracranial pressure: a comparison of different hyperosmotic agents and the use of thiopental.
    Levin AB; Duff TA; Javid MJ
    Neurosurgery; 1979 Nov; 5(5):570-5. PubMed ID: 534065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use.
    Frank MS; Nahata MC; Hilty MD
    Pharmacotherapy; 1981; 1(2):147-60. PubMed ID: 6927604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial doppler monitoring of intracranial pressure therapy with mannitol, sorbitol and glycerol in patients with acute stroke.
    Treib J; Becker SC; Grauer M; Haass A
    Eur Neurol; 1998 Nov; 40(4):212-9. PubMed ID: 9813404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue damage of different submucosal injection solutions for EMR.
    Fujishiro M; Yahagi N; Kashimura K; Matsuura T; Nakamura M; Kakushima N; Kodashima S; Ono S; Kobayashi K; Hashimoto T; Yamamichi N; Tateishi A; Shimizu Y; Oka M; Ichinose M; Omata M
    Gastrointest Endosc; 2005 Dec; 62(6):933-42. PubMed ID: 16301040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Glycerol-induced haemolysis.
    Welch KM; Meyer JS; Okamoto S; Mathew NT; Rivera VM; Bond J
    Lancet; 1974 Mar; 1(7854):416-7. PubMed ID: 4131070
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of oral glycerol on intraventricular pressure in man.
    Rottenberg DA; Hurwitz BJ; Posner JB
    Neurology; 1977 Jul; 27(7):600-8. PubMed ID: 559964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rebound phenomenon of mannitol and glycerol: clinical studies].
    Node Y; Yajima K; Nakazawa S
    No To Shinkei; 1983 Dec; 35(12):1241-6. PubMed ID: 6422967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised intracranial pressure. Diagnosis and management.
    Saper JR; Yosselson S
    Postgrad Med; 1975 Apr; 57(4):89-94. PubMed ID: 1124246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with glycerol of cerebral oedema due to acute cerebral infarction.
    Meyer JS; Charney JZ; Rivera VM; Mathew NT
    Lancet; 1971 Nov; 2(7732):993-7. PubMed ID: 4108107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glycerin and its use in neuropathology].
    Misiuk NS; Iliushina LS; Kriuk GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Sep; 69(9):1333-6. PubMed ID: 5364577
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged control of increased intracranial pressure with glycerin.
    Newkirk TA; Tourtellotte WW; Reinglass JL
    Arch Neurol; 1972 Jul; 27(1):95-6. PubMed ID: 5049685
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():359-63. PubMed ID: 2118716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of regional cerebral blood flow after glycerol infusion in acute cerebral infarction.
    Ott EO; Mathew NT; Meyer JS
    Neurology; 1974 Dec; 24(12):1117-26. PubMed ID: 4475381
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous glycerol therapy should not be used in patients with unrecognized fructose-1,6-bisphosphatase deficiency.
    Hasegawa Y; Kikawa Y; Miyamaoto J; Sugimoto S; Adachi M; Ohura T; Mayumi M
    Pediatr Int; 2003 Feb; 45(1):5-9. PubMed ID: 12654061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glycerol administration on experimental brain edema.
    Guisado R; Arieff AI; Massry SG
    Neurology; 1976 Jan; 26(1):69-75. PubMed ID: 942772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous infusion of glycerol on hemispheric blood flow and metabolism in patients with acute cerebral infarction.
    Meyer JS; Fukuuchi Y; Shimazu K; Ouchi T; Ericsson AD
    Stroke; 1972; 3(2):168-80. PubMed ID: 5011644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.